Andra AP fonden increased its stake in shares of Stryker Corporation (NYSE:SYK) by 3.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 173,100 shares of the medical technology company’s stock after purchasing an additional 5,200 shares during the quarter. Stryker Corporation makes up about 0.6% of Andra AP fonden’s portfolio, making the stock its 21st largest holding. Andra AP fonden’s holdings in Stryker Corporation were worth $24,584,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Parthenon LLC increased its position in Stryker Corporation by 2.5% in the 3rd quarter. Parthenon LLC now owns 44,120 shares of the medical technology company’s stock valued at $6,266,000 after acquiring an additional 1,060 shares during the period. BP PLC increased its position in Stryker Corporation by 12.9% in the 3rd quarter. BP PLC now owns 39,500 shares of the medical technology company’s stock valued at $5,610,000 after acquiring an additional 4,500 shares during the period. Ramsay Stattman Vela & Price Inc. increased its position in Stryker Corporation by 0.7% in the 3rd quarter. Ramsay Stattman Vela & Price Inc. now owns 47,418 shares of the medical technology company’s stock valued at $6,734,000 after acquiring an additional 315 shares during the period. Brightworth increased its position in Stryker Corporation by 2,755.7% in the 3rd quarter. Brightworth now owns 41,751 shares of the medical technology company’s stock valued at $5,930,000 after acquiring an additional 40,289 shares during the period. Finally, Westpac Banking Corp increased its position in Stryker Corporation by 18.5% in the 3rd quarter. Westpac Banking Corp now owns 213,525 shares of the medical technology company’s stock valued at $30,325,000 after acquiring an additional 33,375 shares during the period. Institutional investors and hedge funds own 74.13% of the company’s stock.

Shares of Stryker Corporation (NYSE:SYK) opened at $156.18 on Monday. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $160.62. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. The stock has a market cap of $58,448.43, a PE ratio of 24.75, a P/E/G ratio of 2.46 and a beta of 0.79.

Stryker Corporation (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.50 by $0.02. Stryker Corporation had a net margin of 14.67% and a return on equity of 24.11%. The business had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.97 billion. During the same quarter last year, the company posted $1.39 earnings per share. The firm’s quarterly revenue was up 6.1% compared to the same quarter last year. analysts forecast that Stryker Corporation will post 6.47 EPS for the current fiscal year.

In other Stryker Corporation news, insider Graham A. Mclean sold 1,124 shares of the stock in a transaction dated Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the transaction, the insider now owns 8,983 shares in the company, valued at $1,313,853.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 7.40% of the company’s stock.

Several equities analysts have issued reports on the stock. Oppenheimer Holdings, Inc. set a $156.00 price target on shares of Stryker Corporation and gave the company a “hold” rating in a research report on Monday, October 30th. Robert W. Baird restated a “hold” rating and issued a $161.00 price target on shares of Stryker Corporation in a research report on Friday, October 27th. Barclays PLC upped their price target on shares of Stryker Corporation from $137.00 to $148.00 and gave the company an “underweight” rating in a research report on Friday, October 27th. Wells Fargo & Company upped their price objective on shares of Stryker Corporation from $160.00 to $166.00 in a research note on Friday, October 27th. Finally, Canaccord Genuity upped their price objective on shares of Stryker Corporation from $155.00 to $162.00 and gave the company a “buy” rating in a research note on Friday, October 27th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. Stryker Corporation presently has a consensus rating of “Hold” and a consensus price target of $151.52.

WARNING: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/stryker-corporation-syk-shares-bought-by-andra-ap-fonden/1682968.html.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.